Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Adriana Weinberg

Concepts (834)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
100
2026
3079
10.280
 Why?
Herpes Zoster Vaccine
26
2026
154
9.990
 Why?
Herpes Zoster
33
2025
315
9.220
 Why?
Herpesvirus 3, Human
37
2025
336
7.300
 Why?
Influenza Vaccines
29
2021
529
5.880
 Why?
Cytomegalovirus Infections
28
2024
206
5.840
 Why?
Immunity, Cellular
34
2025
272
5.610
 Why?
Antibodies, Viral
44
2024
672
5.240
 Why?
Pregnancy Complications, Infectious
26
2026
422
4.990
 Why?
T-Lymphocytes, Regulatory
15
2025
388
4.690
 Why?
Cytomegalovirus
27
2024
168
4.240
 Why?
Influenza, Human
27
2021
615
3.950
 Why?
Respiratory Syncytial Virus, Human
7
2026
81
3.360
 Why?
Antiretroviral Therapy, Highly Active
22
2017
277
2.800
 Why?
Immunologic Memory
15
2026
366
2.580
 Why?
Anti-HIV Agents
19
2026
869
2.530
 Why?
Influenza A Virus, H1N1 Subtype
13
2021
157
2.520
 Why?
Pneumococcal Infections
4
2022
103
2.500
 Why?
Vaccines, Attenuated
23
2024
129
2.490
 Why?
T-Lymphocyte Subsets
12
2019
415
2.460
 Why?
T-Lymphocytes
22
2020
1982
2.410
 Why?
Leukocytes, Mononuclear
16
2025
573
2.280
 Why?
CD4-Positive T-Lymphocytes
29
2023
1128
2.070
 Why?
Respiratory Tract Infections
7
2025
396
2.040
 Why?
Respiratory Syncytial Virus Infections
3
2026
136
1.980
 Why?
Isoniazid
7
2026
71
1.700
 Why?
Vaccination
23
2024
1422
1.670
 Why?
Chickenpox
8
2024
81
1.610
 Why?
Humans
240
2026
144261
1.580
 Why?
Antiviral Agents
17
2023
767
1.550
 Why?
Chickenpox Vaccine
11
2024
75
1.540
 Why?
Latent Tuberculosis
2
2026
71
1.540
 Why?
Interferon-gamma
20
2022
784
1.530
 Why?
Tuberculosis
7
2026
289
1.500
 Why?
Female
166
2026
77976
1.460
 Why?
Pregnancy
45
2026
7180
1.460
 Why?
Drug Resistance, Viral
14
2017
122
1.430
 Why?
HIV
8
2022
248
1.410
 Why?
CD8-Positive T-Lymphocytes
12
2019
917
1.330
 Why?
Virus Diseases
4
2018
216
1.330
 Why?
Antitubercular Agents
5
2026
215
1.330
 Why?
DNA, Viral
13
2024
358
1.300
 Why?
Infant
43
2026
10022
1.290
 Why?
Tetanus Toxoid
4
2021
34
1.280
 Why?
Mycobacterium tuberculosis
2
2026
334
1.280
 Why?
Virus Shedding
6
2017
48
1.250
 Why?
Infectious Disease Transmission, Vertical
10
2023
187
1.230
 Why?
Adult
102
2026
40262
1.200
 Why?
Influenza A virus
9
2013
113
1.180
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 7
9
2009
28
1.170
 Why?
Vaccines, Synthetic
8
2026
138
1.170
 Why?
Influenza B virus
9
2017
47
1.160
 Why?
Hepatitis A Vaccines
5
2020
20
1.130
 Why?
Antibodies, Bacterial
5
2022
148
1.120
 Why?
Dermatitis, Atopic
5
2020
321
1.090
 Why?
Male
126
2026
72035
1.090
 Why?
B-Lymphocytes
7
2021
876
1.070
 Why?
Cord Blood Stem Cell Transplantation
3
2023
103
1.070
 Why?
Adjuvants, Immunologic
8
2021
245
1.060
 Why?
CD4 Lymphocyte Count
17
2019
274
1.000
 Why?
HIV-1
13
2019
895
1.000
 Why?
Antibody Formation
7
2023
294
0.990
 Why?
Hemagglutination Inhibition Tests
14
2021
38
0.980
 Why?
Pneumococcal Vaccines
3
2022
130
0.970
 Why?
Anti-Retroviral Agents
8
2023
240
0.960
 Why?
Lymphocyte Activation
26
2020
1126
0.950
 Why?
Transforming Growth Factor beta
4
2025
479
0.950
 Why?
Infant, Newborn
25
2026
6424
0.940
 Why?
Breast Feeding
4
2023
448
0.920
 Why?
Transforming Growth Factor beta1
2
2025
177
0.910
 Why?
Gastrointestinal Microbiome
2
2025
771
0.910
 Why?
Interleukin-2
13
2022
437
0.900
 Why?
Monocytes
2
2025
538
0.880
 Why?
Vaccines, Inactivated
10
2017
70
0.870
 Why?
Respiratory Syncytial Viruses
1
2025
58
0.870
 Why?
Hematopoietic Stem Cell Transplantation
3
2023
674
0.870
 Why?
Enzyme-Linked Immunospot Assay
6
2018
37
0.860
 Why?
Viral Load
18
2023
518
0.850
 Why?
Viremia
9
2021
158
0.850
 Why?
HIV Protease Inhibitors
3
2019
69
0.820
 Why?
Child, Preschool
35
2025
11774
0.790
 Why?
Immune Reconstitution
1
2023
9
0.790
 Why?
Child
54
2025
22537
0.790
 Why?
Epstein-Barr Virus Infections
5
2013
101
0.790
 Why?
Environmental Exposure
2
2018
587
0.760
 Why?
Papillomavirus Vaccines
3
2018
297
0.760
 Why?
Double-Blind Method
18
2026
2025
0.750
 Why?
Receptors, Tumor Necrosis Factor
8
2001
163
0.720
 Why?
Herpesvirus 1, Human
3
2016
84
0.720
 Why?
Cytokines
12
2025
2061
0.710
 Why?
Adolescent
54
2025
22281
0.700
 Why?
Middle Aged
64
2026
35762
0.680
 Why?
Orthomyxoviridae
3
2017
40
0.680
 Why?
Polymerase Chain Reaction
12
2023
1054
0.680
 Why?
Young Adult
30
2026
13990
0.680
 Why?
Aged
43
2026
25850
0.660
 Why?
DNA-Directed DNA Polymerase
4
2008
48
0.640
 Why?
Vitamin D
2
2024
399
0.630
 Why?
Aged, 80 and over
18
2022
8243
0.630
 Why?
Rotavirus Infections
2
2017
35
0.630
 Why?
Viral Proteins
5
2012
355
0.630
 Why?
Rotavirus Vaccines
2
2017
37
0.630
 Why?
Postpartum Period
7
2026
361
0.620
 Why?
Herpesvirus 4, Human
8
2014
176
0.620
 Why?
Immunosuppressive Agents
7
2014
846
0.610
 Why?
Killer Cells, Natural
5
2026
467
0.610
 Why?
Viral Envelope Proteins
2
2021
98
0.590
 Why?
Medroxyprogesterone Acetate
2
2016
37
0.580
 Why?
Respiratory Syncytial Virus Vaccines
1
2019
39
0.570
 Why?
Inflammation
5
2026
2877
0.570
 Why?
RNA, Viral
9
2024
687
0.570
 Why?
Antibodies, Neutralizing
7
2021
340
0.570
 Why?
Paramyxoviridae Infections
2
2011
12
0.560
 Why?
Simplexvirus
9
2016
82
0.560
 Why?
Human papillomavirus 18
1
2018
12
0.560
 Why?
Immunocompromised Host
9
2019
201
0.550
 Why?
Human papillomavirus 16
1
2018
27
0.550
 Why?
Hepatitis A Antibodies
2
2009
3
0.550
 Why?
Cryopreservation
2
2010
110
0.540
 Why?
AIDS-Related Opportunistic Infections
3
2019
130
0.540
 Why?
Th1 Cells
1
2018
139
0.530
 Why?
Lymphocyte Subsets
2
2015
83
0.520
 Why?
Flow Cytometry
11
2019
1172
0.510
 Why?
Antigens, Viral
8
2017
182
0.510
 Why?
Immunoconjugates
2
2013
132
0.510
 Why?
Immunization, Secondary
6
2017
91
0.510
 Why?
Age Factors
9
2019
3313
0.510
 Why?
Immunity, Innate
3
2026
846
0.510
 Why?
Mutation
7
2009
4085
0.500
 Why?
Hospitalization
6
2021
2424
0.500
 Why?
Acyclovir
6
2012
96
0.490
 Why?
Herpesviridae Infections
5
2013
150
0.490
 Why?
Encephalomyelitis, Autoimmune, Experimental
5
1999
66
0.490
 Why?
Premature Birth
2
2019
380
0.480
 Why?
Case-Control Studies
14
2024
3592
0.480
 Why?
Host-Pathogen Interactions
1
2019
371
0.470
 Why?
Immunoglobulin G
8
2026
893
0.470
 Why?
Viral Vaccines
4
2014
107
0.470
 Why?
Herpes Simplex
4
2016
98
0.450
 Why?
T-Lymphocytes, Cytotoxic
3
2011
177
0.450
 Why?
Reagent Kits, Diagnostic
2
2005
34
0.450
 Why?
Contraceptive Agents, Female
1
2016
80
0.440
 Why?
Central Nervous System Viral Diseases
3
2004
78
0.440
 Why?
B-Lymphocyte Subsets
1
2015
80
0.430
 Why?
Immunoassay
5
2017
109
0.430
 Why?
Immunity, Mucosal
2
2012
98
0.420
 Why?
Injections, Intramuscular
4
2017
141
0.420
 Why?
Foscarnet
6
2008
20
0.420
 Why?
Immunophenotyping
6
2019
322
0.400
 Why?
Transplant Recipients
3
2024
180
0.400
 Why?
Antigen-Presenting Cells
4
2022
160
0.390
 Why?
Gene Expression Profiling
3
2019
1782
0.390
 Why?
B-Lymphocytes, Regulatory
1
2013
3
0.390
 Why?
CD4 Antigens
2
2011
139
0.380
 Why?
Abatacept
3
2026
56
0.380
 Why?
Influenza A Virus, H3N2 Subtype
4
2020
50
0.380
 Why?
Reverse Transcriptase Inhibitors
3
2020
87
0.380
 Why?
Staphylococcus aureus
1
2017
454
0.370
 Why?
Immune Tolerance
2
2013
379
0.370
 Why?
Alphapapillomavirus
1
2012
35
0.370
 Why?
Vaccines, Conjugate
2
2022
60
0.360
 Why?
Dendritic Cells
2
2026
499
0.360
 Why?
Candida
3
2010
44
0.360
 Why?
Cell Proliferation
6
2020
2494
0.360
 Why?
Hepatitis A
1
2012
25
0.360
 Why?
Cohort Studies
11
2023
5935
0.360
 Why?
Placebos
5
2017
192
0.360
 Why?
Polysaccharides
2
2022
87
0.360
 Why?
Skin
1
2017
754
0.360
 Why?
CD28 Antigens
3
2009
58
0.350
 Why?
Contraceptive Agents
1
2012
65
0.350
 Why?
Metapneumovirus
1
2011
15
0.350
 Why?
Transplantation
1
2011
33
0.350
 Why?
Herpesvirus 2, Human
2
2012
27
0.340
 Why?
Lymphocyte Count
4
2019
164
0.340
 Why?
Lymphoproliferative Disorders
1
2011
57
0.340
 Why?
Benzoxazines
4
2026
31
0.340
 Why?
T-Lymphocytes, Helper-Inducer
7
1994
131
0.340
 Why?
Blood
2
2009
109
0.330
 Why?
Immunogenicity, Vaccine
5
2026
36
0.330
 Why?
Nucleosides
1
2010
25
0.330
 Why?
Retrospective Studies
21
2024
17009
0.330
 Why?
Drug Therapy, Combination
6
2019
1044
0.330
 Why?
Pregnancy Outcome
7
2021
476
0.320
 Why?
Immunoglobulin A
4
2017
214
0.310
 Why?
Programmed Cell Death 1 Receptor
3
2020
264
0.310
 Why?
Streptococcus pneumoniae
2
2022
177
0.310
 Why?
Cytosine
3
2008
51
0.310
 Why?
Adaptive Immunity
2
2017
169
0.310
 Why?
Glycoproteins
2
2023
355
0.310
 Why?
Nucleotides
1
2010
128
0.310
 Why?
Antidepressive Agents
3
2021
242
0.310
 Why?
Refrigeration
1
2009
12
0.310
 Why?
Membrane Glycoproteins
4
2001
496
0.300
 Why?
Immunity, Humoral
2
2021
120
0.300
 Why?
Enzyme-Linked Immunosorbent Assay
8
2021
850
0.300
 Why?
Follow-Up Studies
16
2024
5389
0.300
 Why?
Organophosphonates
3
2008
97
0.300
 Why?
Astrocytes
1
2011
222
0.300
 Why?
Freezing
1
2009
85
0.290
 Why?
Coculture Techniques
2
2025
246
0.290
 Why?
Cytomegalovirus Retinitis
2
2013
22
0.290
 Why?
Tetanus
2
2009
26
0.290
 Why?
Cyclopropanes
4
2026
83
0.290
 Why?
Alkynes
4
2026
66
0.280
 Why?
Fetal Blood
3
2026
342
0.280
 Why?
Lopinavir
3
2023
30
0.280
 Why?
Interleukin-10
3
2022
309
0.280
 Why?
Time Factors
18
2017
7155
0.270
 Why?
Herpesvirus 7, Human
2
2005
6
0.270
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2008
100
0.270
 Why?
Prospective Studies
14
2024
7970
0.270
 Why?
Herpesvirus 6, Human
2
2005
14
0.270
 Why?
Longitudinal Studies
8
2019
2926
0.270
 Why?
Glioblastoma
1
2011
353
0.270
 Why?
Norgestrel
1
2007
2
0.260
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2017
981
0.260
 Why?
Specimen Handling
1
2009
185
0.260
 Why?
Interleukins
2
2008
248
0.260
 Why?
Apoptosis
6
2011
2430
0.260
 Why?
Biomarkers
7
2021
4254
0.250
 Why?
Incidence
9
2023
2870
0.250
 Why?
Nucleic Acid Hybridization
2
2006
187
0.250
 Why?
Antigens, CD
5
2017
555
0.240
 Why?
Lung Transplantation
4
2002
338
0.230
 Why?
Acetates
2
2023
80
0.230
 Why?
Coinfection
2
2019
141
0.230
 Why?
Lymphokines
5
1994
130
0.230
 Why?
Fibroblasts
4
2025
1032
0.220
 Why?
Bone Marrow Transplantation
2
2005
294
0.220
 Why?
Ritonavir
2
2016
75
0.220
 Why?
A549 Cells
1
2025
75
0.220
 Why?
Dexamethasone
1
2007
370
0.220
 Why?
Receptors, OX40
8
2001
15
0.220
 Why?
Cell Survival
5
2010
1098
0.220
 Why?
Roseolovirus Infections
1
2004
8
0.220
 Why?
Paramyxoviridae
1
2004
2
0.210
 Why?
Measles Vaccine
1
2024
18
0.210
 Why?
Virus Replication
5
2017
529
0.210
 Why?
Chemical and Drug Induced Liver Injury
1
2026
139
0.210
 Why?
Quinazolines
2
2023
266
0.210
 Why?
BCG Vaccine
2
2023
27
0.210
 Why?
Forkhead Transcription Factors
3
2011
202
0.210
 Why?
Ganciclovir
4
2008
53
0.210
 Why?
RNA, Messenger
10
2011
2829
0.210
 Why?
Milk, Human
2
2023
172
0.200
 Why?
Autoimmune Diseases
3
2014
463
0.200
 Why?
Immunity
2
2020
139
0.200
 Why?
Brazil
2
2021
179
0.200
 Why?
Cholecalciferol
1
2024
60
0.200
 Why?
Drug-Related Side Effects and Adverse Reactions
2
2017
257
0.200
 Why?
Estradiol
1
2007
533
0.200
 Why?
Myelin Basic Protein
4
1998
44
0.200
 Why?
Orthomyxoviridae Infections
1
2004
72
0.200
 Why?
Acquired Immunodeficiency Syndrome
2
2023
231
0.200
 Why?
Maternal-Fetal Exchange
2
2016
169
0.200
 Why?
Down-Regulation
1
2025
627
0.200
 Why?
Abnormalities, Drug-Induced
1
2023
32
0.200
 Why?
Kaposi Varicelliform Eruption
3
2011
21
0.190
 Why?
Papillomavirus Infections
2
2018
345
0.190
 Why?
Long-Term Care
1
2024
117
0.190
 Why?
Antirheumatic Agents
1
2026
303
0.190
 Why?
Adenoviridae Infections
1
2023
20
0.190
 Why?
Heart Transplantation
10
2001
736
0.190
 Why?
Isoxazoles
2
2013
53
0.190
 Why?
Diabetes Mellitus, Type 1
4
2013
3842
0.180
 Why?
Zidovudine
2
2015
77
0.180
 Why?
Lamivudine
2
2015
65
0.180
 Why?
Herpes Genitalis
2
2012
17
0.180
 Why?
Liver Failure, Acute
1
2023
67
0.180
 Why?
HIV Integrase Inhibitors
1
2023
77
0.180
 Why?
United States
9
2024
15876
0.180
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2013
97
0.180
 Why?
Genes, Immediate-Early
1
2002
26
0.180
 Why?
Risk Factors
18
2024
10699
0.180
 Why?
South Africa
6
2020
221
0.180
 Why?
Lymphocytosis
1
2021
11
0.180
 Why?
Genes, Viral
1
2002
90
0.180
 Why?
Central Nervous System Diseases
1
2002
74
0.180
 Why?
Antigens, Differentiation
1
2001
77
0.180
 Why?
Tuberculin Test
1
2021
36
0.180
 Why?
Cytotoxicity, Immunologic
2
2002
223
0.170
 Why?
Biliary Atresia
1
2023
157
0.170
 Why?
Interferon-gamma Release Tests
1
2021
32
0.170
 Why?
Organ Transplantation
1
2024
247
0.170
 Why?
Cells, Cultured
11
2010
4146
0.170
 Why?
Phenotype
7
2009
3157
0.170
 Why?
Treatment Outcome
17
2026
11643
0.170
 Why?
Atazanavir Sulfate
2
2023
42
0.170
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
76
0.170
 Why?
Medication Therapy Management
1
2021
73
0.170
 Why?
Maternal Exposure
1
2023
213
0.170
 Why?
Immunoglobulins
2
2017
160
0.160
 Why?
Receptors, Immunologic
2
2000
206
0.160
 Why?
Evolution, Molecular
1
2005
513
0.160
 Why?
Virus Activation
3
2013
95
0.160
 Why?
North America
2
2023
310
0.160
 Why?
Sensitivity and Specificity
5
2009
1983
0.160
 Why?
HIV Seronegativity
1
2020
29
0.160
 Why?
Histocompatibility Antigens Class I
1
2002
202
0.160
 Why?
Virus Cultivation
3
2005
31
0.160
 Why?
RNA, Ribosomal, 16S
1
2022
558
0.160
 Why?
Dietary Supplements
1
2024
575
0.150
 Why?
T-Cell Antigen Receptor Specificity
1
2019
45
0.150
 Why?
Heart-Assist Devices
8
2000
567
0.150
 Why?
Interleukin-2 Receptor alpha Subunit
1
2019
80
0.150
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
2017
13
0.150
 Why?
Eicosanoids
1
2019
58
0.150
 Why?
Survival Analysis
6
2018
1382
0.150
 Why?
Dose-Response Relationship, Immunologic
2
2016
76
0.140
 Why?
Cholera Toxin
1
2018
29
0.140
 Why?
Arthritis, Rheumatoid
2
2026
1168
0.140
 Why?
Postoperative Complications
14
2001
2916
0.140
 Why?
Hospitals
1
2023
727
0.140
 Why?
Saliva
2
2010
249
0.140
 Why?
Genotype
6
2020
1833
0.140
 Why?
Delayed-Action Preparations
2
2016
183
0.140
 Why?
Latin America
1
2018
93
0.140
 Why?
Fatty Acid-Binding Proteins
1
2018
79
0.140
 Why?
Cell Movement
2
2001
965
0.130
 Why?
Neurodevelopmental Disorders
1
2021
226
0.130
 Why?
CD4-CD8 Ratio
2
2008
23
0.130
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
12
0.130
 Why?
Vaccination Coverage
1
2018
102
0.130
 Why?
Cell Line
5
2009
2879
0.130
 Why?
Injections, Intradermal
1
2017
11
0.130
 Why?
Coronary Artery Bypass
4
2001
268
0.130
 Why?
Injections, Subcutaneous
2
2016
164
0.130
 Why?
Paralysis
1
2017
67
0.130
 Why?
Nervous System Diseases
1
2020
282
0.130
 Why?
Arm
1
2017
109
0.120
 Why?
Placenta
2
2021
780
0.120
 Why?
Seroconversion
1
2017
49
0.120
 Why?
Africa
1
2017
114
0.120
 Why?
Kinetics
3
2010
1627
0.120
 Why?
Nelfinavir
1
2016
8
0.120
 Why?
Adoptive Transfer
3
2002
198
0.120
 Why?
Animals
24
2011
38030
0.120
 Why?
Clinical Trials as Topic
2
2019
1050
0.120
 Why?
Seizures
1
2020
460
0.120
 Why?
Cross Reactions
2
2014
130
0.120
 Why?
Base Sequence
6
2017
2187
0.120
 Why?
Demography
2
2018
284
0.120
 Why?
Colorado
2
2023
4562
0.120
 Why?
Liver Transplantation
1
2023
822
0.110
 Why?
Comorbidity
2
2019
1646
0.110
 Why?
Aging
3
2017
1964
0.110
 Why?
Nevirapine
1
2015
18
0.110
 Why?
RNA
1
2022
939
0.110
 Why?
Contraceptives, Oral, Synthetic
1
2015
1
0.110
 Why?
Nasopharynx
1
2015
73
0.110
 Why?
Nasal Lavage Fluid
2
2005
15
0.110
 Why?
Infant, Newborn, Diseases
1
2016
113
0.110
 Why?
Immunoenzyme Techniques
2
2006
200
0.110
 Why?
Skin Diseases
1
2016
149
0.110
 Why?
Virus Latency
2
2013
90
0.110
 Why?
Neutropenia
1
2015
155
0.110
 Why?
Transcription, Genetic
1
2021
1495
0.110
 Why?
Multivariate Analysis
5
2017
1533
0.110
 Why?
Seroepidemiologic Studies
2
2024
172
0.100
 Why?
Computational Biology
1
2019
680
0.100
 Why?
Antigens, Differentiation, T-Lymphocyte
1
1994
100
0.100
 Why?
Graft Rejection
5
2001
540
0.100
 Why?
Pandemics
2
2021
1682
0.100
 Why?
Physical Fitness
1
2015
209
0.100
 Why?
Herpesvirus 8, Human
2
2005
68
0.100
 Why?
Drug Resistance, Multiple, Viral
1
2013
10
0.100
 Why?
Anemia
1
2015
187
0.100
 Why?
Progesterone
2
2015
255
0.100
 Why?
Feces
1
2017
513
0.100
 Why?
Thrombocytopenia
1
2015
205
0.100
 Why?
Leukocyte Common Antigens
2
2009
88
0.100
 Why?
Polyomavirus Infections
1
2013
29
0.100
 Why?
Anesthesiology
1
2016
175
0.100
 Why?
Tumor Virus Infections
1
2013
49
0.100
 Why?
Epitopes, T-Lymphocyte
1
2014
175
0.100
 Why?
Epitopes
2
2009
485
0.100
 Why?
OX40 Ligand
4
2001
10
0.090
 Why?
Mothers
1
2019
774
0.090
 Why?
Transcriptome
1
2019
1044
0.090
 Why?
Proctitis
1
2012
6
0.090
 Why?
Oxadiazoles
1
2012
37
0.090
 Why?
HIV Seropositivity
1
2013
118
0.090
 Why?
Oxidative Stress
1
2019
1339
0.090
 Why?
Rats, Inbred Lew
4
1998
103
0.090
 Why?
Interferon Regulatory Factor-2
1
2011
3
0.090
 Why?
Aprotinin
3
1997
11
0.090
 Why?
DNA Primase
1
2012
47
0.090
 Why?
Communicable Diseases
1
2014
163
0.090
 Why?
Mycophenolic Acid
1
2012
120
0.090
 Why?
Depression
1
2021
1533
0.090
 Why?
Fluorescent Antibody Technique, Direct
1
2011
9
0.090
 Why?
Viral Plaque Assay
3
2006
29
0.090
 Why?
L-Selectin
2
2009
27
0.090
 Why?
Receptors, Interleukin-2
2
1990
64
0.080
 Why?
Histocompatibility Testing
3
2001
121
0.080
 Why?
CD8 Antigens
1
2011
72
0.080
 Why?
Encephalitis, Viral
2
2020
45
0.080
 Why?
Guanine
3
2006
87
0.080
 Why?
Ribavirin
1
2011
80
0.080
 Why?
Immunization Schedule
3
2020
187
0.080
 Why?
DNA Helicases
1
2012
143
0.080
 Why?
Fluorescent Antibody Technique
2
2016
370
0.080
 Why?
Motor Activity
1
2015
720
0.080
 Why?
Parturition
1
2011
68
0.080
 Why?
Logistic Models
5
2010
2104
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Predictive Value of Tests
3
2005
2111
0.080
 Why?
Length of Stay
3
2014
1335
0.080
 Why?
Menstrual Cycle
1
2011
140
0.080
 Why?
Algorithms
3
2021
1834
0.080
 Why?
Immune System
2
2008
179
0.080
 Why?
Granzymes
1
2009
49
0.080
 Why?
Herpes Simplex Virus Vaccines
1
2009
4
0.080
 Why?
Pokeweed Mitogens
1
2009
7
0.080
 Why?
Human Experimentation
1
2009
12
0.080
 Why?
Neuralgia, Postherpetic
1
2009
39
0.080
 Why?
Pilot Projects
2
2026
1867
0.070
 Why?
Immunologic Factors
1
2011
255
0.070
 Why?
Drug Stability
1
2009
164
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
186
0.070
 Why?
Plasma
2
2018
224
0.070
 Why?
Tumor Necrosis Factor-alpha
1
2014
1217
0.070
 Why?
Gene Rearrangement, T-Lymphocyte
1
2008
16
0.070
 Why?
Cost of Illness
1
2011
319
0.070
 Why?
Nasal Mucosa
1
2009
112
0.070
 Why?
Inflammation Mediators
1
2011
508
0.070
 Why?
Mice
13
2011
18329
0.070
 Why?
Enzyme Inhibitors
1
2012
824
0.070
 Why?
Botswana
2
2019
9
0.070
 Why?
Infant Mortality
2
2019
123
0.070
 Why?
Betaherpesvirinae
1
2008
1
0.070
 Why?
Genetic Variation
2
2011
982
0.070
 Why?
Administration, Intranasal
1
2008
93
0.070
 Why?
Exodeoxyribonucleases
1
2008
28
0.070
 Why?
Interleukin-15
1
2008
97
0.070
 Why?
Cyclosporine
2
2001
265
0.070
 Why?
Interleukin-12
1
2008
117
0.070
 Why?
Rats
5
1998
5592
0.070
 Why?
Trypan Blue
1
2007
5
0.070
 Why?
Didanosine
1
2007
13
0.070
 Why?
Sarcoma
1
2010
205
0.070
 Why?
Thymus Gland
1
2008
311
0.070
 Why?
Gene Expression
3
2006
1487
0.070
 Why?
In Vitro Techniques
3
2006
1047
0.060
 Why?
Data Interpretation, Statistical
1
2009
371
0.060
 Why?
Quality Control
1
2007
163
0.060
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2010
293
0.060
 Why?
Cerebrospinal Fluid
2
2004
88
0.060
 Why?
Pneumonia
1
2013
630
0.060
 Why?
Inhibitory Concentration 50
1
2006
91
0.060
 Why?
Vero Cells
1
2006
84
0.060
 Why?
Transfection
3
2002
938
0.060
 Why?
Drug Interactions
2
2020
397
0.060
 Why?
Randomized Controlled Trials as Topic
2
2011
1705
0.060
 Why?
Multicenter Studies as Topic
2
2006
402
0.060
 Why?
Veterans
1
2018
1600
0.060
 Why?
Antibodies, Monoclonal, Humanized
1
2012
985
0.060
 Why?
Deoxycytidine
1
2007
221
0.060
 Why?
Opportunistic Infections
2
2014
45
0.060
 Why?
Protein Structure, Tertiary
1
2008
862
0.060
 Why?
Hemostatics
2
1997
61
0.060
 Why?
Hemadsorption
1
2005
1
0.060
 Why?
Risk Assessment
2
2014
3637
0.060
 Why?
Cytopathogenic Effect, Viral
1
2005
16
0.060
 Why?
Tumor Necrosis Factors
3
2001
10
0.060
 Why?
Disease Models, Animal
2
2011
4556
0.060
 Why?
Signal Transduction
2
2000
5221
0.060
 Why?
Evaluation Studies as Topic
1
2005
166
0.060
 Why?
Gene Products, pol
1
2005
6
0.060
 Why?
Annexin A5
1
2004
21
0.060
 Why?
Clinical Trials, Phase II as Topic
2
2017
77
0.050
 Why?
Cysteine Proteinase Inhibitors
1
2004
50
0.050
 Why?
Antigens
2
2008
347
0.050
 Why?
Meningitis, Viral
1
2004
20
0.050
 Why?
Pharmacogenetics
1
2026
172
0.050
 Why?
Parainfluenza Virus 2, Human
1
2004
3
0.050
 Why?
Parainfluenza Virus 1, Human
1
2004
3
0.050
 Why?
Parainfluenza Virus 3, Human
1
2004
5
0.050
 Why?
Measles virus
1
2024
21
0.050
 Why?
Sarcoma, Kaposi
2
2003
83
0.050
 Why?
Transplantation, Homologous
2
2002
415
0.050
 Why?
Disease Transmission, Infectious
1
2005
69
0.050
 Why?
Adenoviruses, Human
1
2004
26
0.050
 Why?
Emtricitabine
2
2021
205
0.050
 Why?
Fatal Outcome
1
2005
307
0.050
 Why?
Cell Culture Techniques
1
2006
375
0.050
 Why?
Immunotherapy, Adoptive
2
2001
337
0.050
 Why?
Chlamydophila Infections
1
2003
5
0.050
 Why?
Chlamydophila pneumoniae
1
2003
12
0.050
 Why?
Measles
1
2024
46
0.050
 Why?
HLA-DR Antigens
3
2001
220
0.050
 Why?
Rilpivirine
1
2023
10
0.050
 Why?
Survival Rate
8
2001
2088
0.050
 Why?
Arteriosclerosis
1
2003
84
0.050
 Why?
Portoenterostomy, Hepatic
1
2023
43
0.050
 Why?
Bronchiolitis Obliterans
2
2001
66
0.050
 Why?
Darunavir
1
2023
20
0.050
 Why?
Hospital Mortality
4
2001
1027
0.050
 Why?
Herpes Labialis
1
2003
8
0.050
 Why?
Cell Line, Tumor
1
2011
3539
0.050
 Why?
Leukemia, Myeloid, Acute
1
2010
682
0.050
 Why?
DNA Primers
3
2009
511
0.050
 Why?
Respirovirus
1
2002
6
0.050
 Why?
Pregnancy Trimester, First
1
2023
135
0.050
 Why?
Receptors, Antigen, T-Cell, alpha-beta
2
1994
331
0.050
 Why?
Bronchoalveolar Lavage Fluid
1
2005
636
0.050
 Why?
Risk
1
2005
909
0.050
 Why?
Parapsychology
1
2001
1
0.050
 Why?
Adenoviridae
1
2023
199
0.040
 Why?
Electromagnetic Fields
1
2001
37
0.040
 Why?
Zimbabwe
2
2017
74
0.040
 Why?
B7-1 Antigen
2
1998
55
0.040
 Why?
Microbial Sensitivity Tests
1
2003
370
0.040
 Why?
Ovalbumin
1
2001
190
0.040
 Why?
Molecular Sequence Data
4
1994
2929
0.040
 Why?
Cobicistat
1
2021
5
0.040
 Why?
Receptors, CXCR5
1
2021
27
0.040
 Why?
CTLA-4 Antigen
1
2001
104
0.040
 Why?
Rituximab
2
2013
209
0.040
 Why?
Antibody Affinity
1
2021
60
0.040
 Why?
Photography
1
2001
115
0.040
 Why?
Immunoglobulins, Intravenous
1
2002
126
0.040
 Why?
Liver Diseases
1
2024
304
0.040
 Why?
Vaccines, Subunit
1
2021
53
0.040
 Why?
Prostheses and Implants
3
1996
141
0.040
 Why?
Arylamine N-Acetyltransferase
1
2020
8
0.040
 Why?
Lymphoma
1
2002
232
0.040
 Why?
Cytochrome P-450 CYP2B6
1
2020
9
0.040
 Why?
Gene Expression Regulation
1
1990
2603
0.040
 Why?
Equivalence Trials as Topic
1
2020
35
0.040
 Why?
Pre-Eclampsia
1
2023
204
0.040
 Why?
Analysis of Variance
2
2016
1304
0.040
 Why?
Models, Statistical
1
2005
677
0.040
 Why?
Sentinel Lymph Node Biopsy
1
2001
118
0.040
 Why?
Metabolic Clearance Rate
1
2020
114
0.040
 Why?
Living Donors
1
2023
280
0.040
 Why?
Surface Properties
1
2001
410
0.040
 Why?
Glioma
1
2005
425
0.040
 Why?
DNA
2
2006
1460
0.040
 Why?
Spinal Cord
2
1994
380
0.040
 Why?
Central Nervous System Neoplasms
1
2002
173
0.040
 Why?
Lymphatic Metastasis
1
2001
333
0.040
 Why?
Trans-Activators
1
2002
405
0.040
 Why?
Heart Failure
3
1999
2314
0.040
 Why?
Confusion
1
2020
30
0.040
 Why?
Alanine
1
2021
171
0.040
 Why?
Cancer Vaccines
1
2001
160
0.040
 Why?
Hemodynamics
3
2001
1119
0.040
 Why?
Interleukin-3
3
1994
23
0.040
 Why?
Coronary Disease
2
2001
381
0.040
 Why?
Antibodies
1
2001
401
0.040
 Why?
Liver Function Tests
1
2019
106
0.040
 Why?
Candidiasis
1
1999
64
0.040
 Why?
California
2
2015
469
0.040
 Why?
Triiodothyronine
1
1999
54
0.040
 Why?
Prognosis
3
2024
4278
0.040
 Why?
Recombinant Fusion Proteins
2
1999
674
0.040
 Why?
Infant, Very Low Birth Weight
1
2019
73
0.040
 Why?
Hemagglutination
1
2018
7
0.040
 Why?
Macrophage-1 Antigen
1
1999
26
0.040
 Why?
Hypoplastic Left Heart Syndrome
1
2000
120
0.040
 Why?
Mice, Inbred BALB C
1
2001
1253
0.040
 Why?
Polymorphism, Single Nucleotide
3
2011
2143
0.040
 Why?
Arginine Vasopressin
1
1998
44
0.040
 Why?
Tenofovir
1
2021
295
0.040
 Why?
Cross-Sectional Studies
3
2024
5813
0.040
 Why?
Brain Diseases
1
2020
152
0.040
 Why?
Adenine
1
2021
339
0.030
 Why?
Neoplasms
3
2001
2870
0.030
 Why?
HLA-B Antigens
1
1998
56
0.030
 Why?
Haptoglobins
1
2018
66
0.030
 Why?
Chronic Disease
1
2024
1812
0.030
 Why?
Vasoconstrictor Agents
1
1998
144
0.030
 Why?
Delivery, Obstetric
1
2019
160
0.030
 Why?
Antibody Specificity
1
1998
181
0.030
 Why?
Immunization
1
2020
374
0.030
 Why?
Protein Precursors
1
2018
136
0.030
 Why?
Clinical Trials, Phase I as Topic
1
2017
52
0.030
 Why?
Inositol Phosphates
1
2017
21
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Shock
1
1998
108
0.030
 Why?
Autogenic Training
1
1997
1
0.030
 Why?
Proviruses
1
2017
16
0.030
 Why?
Radioactive Fallout
1
1997
1
0.030
 Why?
Leukemia, Radiation-Induced
1
1997
4
0.030
 Why?
Product Surveillance, Postmarketing
1
2017
72
0.030
 Why?
Radioactive Hazard Release
1
1997
5
0.030
 Why?
Sequence Analysis
1
2017
35
0.030
 Why?
Observational Studies as Topic
1
2017
129
0.030
 Why?
Power Plants
1
1997
10
0.030
 Why?
Relaxation Therapy
1
1997
19
0.030
 Why?
Zambia
1
2017
56
0.030
 Why?
Tanzania
1
2017
62
0.030
 Why?
Encephalitis
1
1998
139
0.030
 Why?
Reproducibility of Results
1
2005
3403
0.030
 Why?
Ligands
1
1999
673
0.030
 Why?
Heart Valves
1
1997
43
0.030
 Why?
Lung Injury
1
2000
237
0.030
 Why?
Aortic Valve Insufficiency
1
1996
43
0.030
 Why?
Prevalence
2
2018
2815
0.030
 Why?
Erythema
1
2016
28
0.030
 Why?
Body Weight
1
2020
976
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
2016
29
0.030
 Why?
Neoplasms, Radiation-Induced
1
1997
99
0.030
 Why?
Up-Regulation
2
2001
851
0.030
 Why?
Fiber Optic Technology
1
2016
24
0.030
 Why?
Heart Arrest, Induced
1
1995
34
0.030
 Why?
Thromboembolism
1
1996
125
0.030
 Why?
Chi-Square Distribution
2
2013
527
0.030
 Why?
Graft vs Host Disease
1
1998
264
0.030
 Why?
Vasodilation
1
1998
522
0.030
 Why?
Intestines
1
2018
358
0.030
 Why?
Reference Values
2
2011
797
0.030
 Why?
Interleukin-4
2
1998
206
0.030
 Why?
DNA-Binding Proteins
1
2002
1497
0.030
 Why?
Single-Blind Method
1
2016
311
0.030
 Why?
Blood Transfusion
2
1995
405
0.030
 Why?
Ovulation
1
2015
41
0.030
 Why?
Registries
1
2024
2382
0.030
 Why?
Hematologic Neoplasms
1
1997
161
0.030
 Why?
Antibodies, Monoclonal
2
2001
1519
0.030
 Why?
Gene Regulatory Networks
1
2017
318
0.030
 Why?
Cross Infection
1
1997
262
0.030
 Why?
Hypothermia, Induced
1
1995
96
0.030
 Why?
Rats, Inbred BUF
1
1994
1
0.030
 Why?
Liver
1
2023
1884
0.030
 Why?
Blood Loss, Surgical
1
1995
112
0.030
 Why?
HLA-A2 Antigen
1
2014
35
0.030
 Why?
Surgical Wound Infection
1
1997
316
0.030
 Why?
Pulmonary Emphysema
1
1996
275
0.030
 Why?
Aortic Coarctation
1
1994
79
0.030
 Why?
Polymorphism, Restriction Fragment Length
2
2003
64
0.030
 Why?
Colony-Stimulating Factors
2
1990
37
0.020
 Why?
Cross-Over Studies
1
2016
600
0.020
 Why?
Aortic Valve
1
1996
360
0.020
 Why?
Quality of Life
4
2000
3166
0.020
 Why?
Myocardial Infarction
1
2001
1208
0.020
 Why?
BK Virus
1
2013
17
0.020
 Why?
Growth Substances
2
1990
140
0.020
 Why?
Cause of Death
3
2001
464
0.020
 Why?
JC Virus
1
2013
23
0.020
 Why?
Intubation, Intratracheal
1
2016
320
0.020
 Why?
Herpesviridae
1
2012
22
0.020
 Why?
Mice, Inbred Strains
2
1990
397
0.020
 Why?
Drug Administration Schedule
2
2007
778
0.020
 Why?
Genetic Predisposition to Disease
2
2011
2359
0.020
 Why?
Cardiac Surgical Procedures
1
1998
609
0.020
 Why?
Hypersensitivity, Delayed
1
1992
29
0.020
 Why?
Ventricular Function, Left
1
1995
538
0.020
 Why?
Heart Diseases
1
1995
349
0.020
 Why?
Brain Neoplasms
1
2001
1318
0.020
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
1990
161
0.020
 Why?
Spleen
1
1994
508
0.020
 Why?
Kaplan-Meier Estimate
1
2014
964
0.020
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2001
1953
0.020
 Why?
Ambulatory Care
1
1996
597
0.020
 Why?
Histocompatibility Antigens
1
1992
102
0.020
 Why?
Sex Characteristics
1
2017
789
0.020
 Why?
Patient Selection
1
1995
719
0.020
 Why?
Metabolomics
1
2017
726
0.020
 Why?
Computer Simulation
1
2016
1025
0.020
 Why?
Matched-Pair Analysis
1
2011
37
0.020
 Why?
Receptors, Interferon
1
2011
60
0.020
 Why?
Kidney Failure, Chronic
1
1997
597
0.020
 Why?
Age of Onset
1
2012
536
0.020
 Why?
Administration, Oral
1
2013
847
0.020
 Why?
Stroke
1
2000
1254
0.020
 Why?
Cattle
2
1990
999
0.020
 Why?
Radiotherapy
2
2005
206
0.020
 Why?
Polyribosomes
1
1990
22
0.020
 Why?
Cell Separation
1
2011
307
0.020
 Why?
Lung Neoplasms
2
2001
2637
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1990
157
0.020
 Why?
Concanavalin A
1
1990
71
0.020
 Why?
Tetradecanoylphorbol Acetate
1
1990
153
0.020
 Why?
Regulatory Sequences, Nucleic Acid
1
1990
96
0.020
 Why?
Blotting, Northern
1
1990
204
0.020
 Why?
Haplotypes
1
2011
490
0.020
 Why?
Papillomaviridae
1
2010
115
0.020
 Why?
Genetic Association Studies
1
2011
372
0.020
 Why?
Infant, Premature
1
2014
611
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
Practice Guidelines as Topic
1
2017
1559
0.020
 Why?
Cell Division
2
2002
766
0.020
 Why?
Herpesvirus 1, Bovine
1
1989
3
0.020
 Why?
Mice, Knockout
2
2011
3119
0.020
 Why?
Anxiety
1
1997
1104
0.020
 Why?
Prenatal Exposure Delayed Effects
1
2016
674
0.020
 Why?
Immunoglobulin E
1
2010
315
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
758
0.020
 Why?
Reference Standards
1
2009
177
0.020
 Why?
Hematopoietic Stem Cells
2
1990
420
0.020
 Why?
Ribosomes
1
1990
191
0.020
 Why?
Phylogeny
1
2013
1015
0.020
 Why?
Multiple Sclerosis
1
1994
484
0.020
 Why?
Linear Models
1
2010
850
0.020
 Why?
Infusions, Intravenous
2
1999
423
0.020
 Why?
Membrane Proteins
1
1994
1165
0.020
 Why?
Clinical Competence
1
2016
1241
0.020
 Why?
Time
1
2007
86
0.020
 Why?
Protein Biosynthesis
1
1990
458
0.020
 Why?
Drug Resistance, Multiple
1
2006
25
0.020
 Why?
Kidney Transplantation
1
2013
704
0.020
 Why?
Antineoplastic Agents
2
2010
2192
0.020
 Why?
Clinical Protocols
1
2007
282
0.010
 Why?
Templates, Genetic
1
2005
63
0.010
 Why?
Postoperative Care
2
1999
288
0.010
 Why?
Cell Differentiation
4
2000
2048
0.010
 Why?
Codon
1
2005
94
0.010
 Why?
Internship and Residency
1
2016
1255
0.010
 Why?
Interleukin-5
2
1998
39
0.010
 Why?
Diagnosis, Differential
1
2009
1487
0.010
 Why?
DNA Replication
1
2006
250
0.010
 Why?
Mice, Transgenic
2
2000
2182
0.010
 Why?
Age Distribution
1
2005
397
0.010
 Why?
Sex Distribution
1
2005
380
0.010
 Why?
Vaccines
1
2009
389
0.010
 Why?
Creatinine
2
1997
505
0.010
 Why?
Abdominal Neoplasms
1
2003
47
0.010
 Why?
Lung
1
1996
4108
0.010
 Why?
Endemic Diseases
1
2003
33
0.010
 Why?
Disease Progression
1
2010
2840
0.010
 Why?
Peptide Fragments
2
1998
698
0.010
 Why?
Sequence Analysis, DNA
1
2005
824
0.010
 Why?
Bioelectric Energy Sources
1
2001
4
0.010
 Why?
Neuroblastoma
1
2003
174
0.010
 Why?
Fibrosarcoma
1
2001
23
0.010
 Why?
Galvanic Skin Response
1
2001
26
0.010
 Why?
Electricity
1
2001
27
0.010
 Why?
Electric Conductivity
1
2001
84
0.010
 Why?
Actuarial Analysis
1
2001
21
0.010
 Why?
Injections, Intravenous
1
2001
200
0.010
 Why?
Melanoma, Experimental
1
2001
108
0.010
 Why?
Fingers
1
2001
107
0.010
 Why?
HLA-A Antigens
1
2001
52
0.010
 Why?
Anticoagulants
2
1996
721
0.010
 Why?
Myocardial Revascularization
1
2001
85
0.010
 Why?
Statistics, Nonparametric
1
2001
427
0.010
 Why?
Muscle, Smooth, Vascular
1
2003
452
0.010
 Why?
Immune Sera
1
2000
77
0.010
 Why?
Lymphocytes, Tumor-Infiltrating
1
2001
154
0.010
 Why?
Amino Acid Sequence
2
1994
2154
0.010
 Why?
Probability
1
2001
308
0.010
 Why?
Clone Cells
1
2000
266
0.010
 Why?
Mice, Inbred C57BL
2
2001
5988
0.010
 Why?
Emergency Treatment
1
2001
124
0.010
 Why?
Databases as Topic
1
2000
71
0.010
 Why?
New York
1
2000
124
0.010
 Why?
Carotid Artery Diseases
1
2000
68
0.010
 Why?
Students
1
2005
661
0.010
 Why?
Peripheral Vascular Diseases
1
2000
103
0.010
 Why?
Columbidae
1
1998
31
0.010
 Why?
Cytochrome c Group
1
1998
43
0.010
 Why?
Cardiotonic Agents
1
1999
95
0.010
 Why?
Lymph Nodes
1
2001
502
0.010
 Why?
Cardiac Output
1
1999
179
0.010
 Why?
Life Tables
1
1998
21
0.010
 Why?
Endocardium
1
1998
31
0.010
 Why?
Temperature
1
2001
678
0.010
 Why?
Aortic Diseases
1
2000
124
0.010
 Why?
Vascular Resistance
1
1999
366
0.010
 Why?
Calcinosis
1
2000
233
0.010
 Why?
Cell Death
1
1999
383
0.010
 Why?
Renal Insufficiency
1
2000
168
0.010
 Why?
Hypotension
1
1998
126
0.010
 Why?
Cardiopulmonary Bypass
1
2000
221
0.010
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
1998
221
0.010
 Why?
Phosphorylation
1
2002
1732
0.010
 Why?
Endocarditis, Bacterial
1
1997
44
0.010
 Why?
Ukraine
1
1997
34
0.010
 Why?
Odds Ratio
1
2000
1072
0.010
 Why?
Dose-Response Relationship, Drug
1
2001
2026
0.010
 Why?
Models, Structural
1
1996
41
0.010
 Why?
Lung Volume Measurements
1
1996
46
0.010
 Why?
Radiometry
1
1997
56
0.010
 Why?
Histocompatibility Antigens Class II
1
1998
364
0.010
 Why?
Epidemiologic Methods
1
1997
89
0.010
 Why?
Ultrasonography, Doppler, Transcranial
1
1996
48
0.010
 Why?
Health Care Costs
1
2000
421
0.010
 Why?
Cardiac Output, Low
1
1996
54
0.010
 Why?
Equipment Failure
1
1996
115
0.010
 Why?
Urogenital Neoplasms
1
1995
5
0.010
 Why?
Vital Capacity
1
1996
290
0.010
 Why?
Europe
1
1997
412
0.010
 Why?
Pneumonia, Viral
1
2001
382
0.010
 Why?
Neoplasms, Second Primary
1
1997
100
0.010
 Why?
Forced Expiratory Volume
1
1996
448
0.010
 Why?
Models, Cardiovascular
1
1996
195
0.010
 Why?
Blood Urea Nitrogen
1
1995
53
0.010
 Why?
Heart Valve Prosthesis
1
1997
128
0.010
 Why?
Acute Disease
1
1998
1028
0.010
 Why?
Aortic Aneurysm
1
1995
70
0.010
 Why?
Heart Rate
1
1999
849
0.010
 Why?
Child Development
1
2000
484
0.010
 Why?
Receptors, Antigen, T-Cell
1
1998
668
0.010
 Why?
Biopsy
1
1998
1075
0.010
 Why?
Equipment Design
1
1996
530
0.010
 Why?
Hodgkin Disease
1
1997
171
0.010
 Why?
Proportional Hazards Models
1
1998
1322
0.010
 Why?
Waiting Lists
1
1996
263
0.010
 Why?
Heart Septal Defects, Ventricular
1
1994
46
0.010
 Why?
Interviews as Topic
1
1997
898
0.010
 Why?
Reoperation
1
1997
629
0.010
 Why?
Exercise Test
1
1996
634
0.010
 Why?
Cell Adhesion
1
1994
454
0.010
 Why?
Myocardium
1
1998
939
0.010
 Why?
Thyroid Neoplasms
1
1997
343
0.010
 Why?
Smoking
1
2000
1468
0.010
 Why?
Patient Compliance
1
1997
585
0.010
 Why?
Ventricular Function, Right
1
1995
297
0.010
 Why?
Central Nervous System
1
1994
281
0.010
 Why?
Feasibility Studies
1
1996
1087
0.010
 Why?
Blood Pressure
1
1998
1759
0.010
 Why?
Diabetes Mellitus
1
2000
1092
0.010
 Why?
Head and Neck Neoplasms
1
1995
556
0.010
 Why?
Research Design
1
1997
1129
0.010
 Why?
Lymphocyte Cooperation
1
1990
50
0.000
 Why?
Receptors, Lymphocyte Homing
1
1990
15
0.000
 Why?
Thymectomy
1
1990
15
0.000
 Why?
Antilymphocyte Serum
1
1990
61
0.000
 Why?
Antigens, Surface
1
1990
157
0.000
 Why?
Rabbits
1
1990
648
0.000
 Why?
Infectious Bovine Rhinotracheitis
1
1989
1
0.000
 Why?
Phorbol Esters
1
1989
13
0.000
 Why?
Ionomycin
1
1989
22
0.000
 Why?
Ethers
1
1989
19
0.000
 Why?
Immunotherapy
1
1994
652
0.000
 Why?
Isoantigens
1
1988
17
0.000
 Why?
Kidney
1
1997
1495
0.000
 Why?
Cell-Free System
1
1988
53
0.000
 Why?
Surveys and Questionnaires
1
2000
6021
0.000
 Why?
Breast Neoplasms
1
1997
2447
0.000
 Why?
Models, Biological
1
1988
1820
0.000
 Why?
Weinberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (834) concept(s)
_
Co-Authors Expand Description
See all (66) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)